HealthQuill Zurzuvae
The USFDA has green-lighted the first oral medication indicated to treat postpartum depression in women, which occurs after childbirth or during the later stages of pregnancy.
Drugs Health Pharma

FDA clears first oral drug to treat postpartum depression or ‘baby blues’

HQ Team August 5, 2023: The USFDA has green-lighted the first oral medication indicated to treat postpartum depression in women, which occurs after.

Read More
X